Information about Bard IVC Filter Lawsuits from Lawyers Handling IVC Filter Lawsuits

No-Cost, No-Obligation Bard IVC Filter Lawsuit Review

IVC Filter Lawsuits

IVC Filters May Do Nothing To Prevent Death Or Pulmonary Embolism For Trauma Patients

Bard IVC Filter Lawsuits

One study concluded that surgeons reach for an IVC filter too often, before exhausting all anticoagulant medication option

Thursday, December 16, 2021 - Physicians may be relying on the IVC filter in more cases than what is good for the patient. The intended purpose of the IVC filter is to capture blood clots as a last resort when all chemical anticoagulants have failed. Traumatic brain injuries (TBI) patients needing surgery were given anticoagulants in the past, and are now being implanted with the IVC filter as standard practice. This is true for patients with traumatic brain injuries where an IVC filter may not be the best solution. A study conducted recently and authored by Kwok Ho, Ph.D. at the Royal Perth Hospital, Australia, calls into question whether or not IVC filters work at all, and if they were ever needed to begin with. IVC filter lawsuits are being filed by patients that have experienced injury or loved ones who have died as a result of a defective IVC filter. The study dealt with trauma patients, those who have experienced a life-threatening injury or wound. The study concluded that the IVC filter was of no benefit to trauma patients for several months after insertion of the spider-like blood clot trapping medical device. According to TCTMD.com, "The latest study to tackle the safety and efficacy of inferior vena cava (IVC) filters--this time in trauma patients--has found no benefit of device insertion in reducing symptomatic pulmonary embolism (PE) or death at 90 days." An IVC filter is a mechanical device inserted into the inferior vena cava to trap blood clots before reaching the lungs or heart. The study was presented at the International Society on Thrombosis and Haemostasis and published in the New England Journal of Medicine. The study cites that pulmonary embolism occurs in about 10% of patients that experienced a traumatic injury. The study looked at 240 patients with severe brain injuries. Patients were unable to receive anticoagulant medication, and some had the IVC filter implanted within the first 72 hours after injury, and others did not have one implanted at all. The conclusion was that there was no difference in the death rate or rate of pulmonary embolism between the two groups. The doctor also told his audience that he thought IVC filters have a place in patients that were most seriously injured and would have died without one. He also said that his research led him to believe that surgeons may be over-relying on the device because of advances in retrieval techniques such as lasers. IVC filters must be removed soon after they are implanted to prevent Bard IVC filter complications, as per the guidance of the medical establishment and the Food and Drug Administration. Failure to remove an IVC filter promptly could cause it to become encases in scar tissue. Doctors inexperienced in retrieving IVC filters could exert excessive force and pull or yank on the device, breaking it, and allowing the metal shards to lacerate the lungs or become embedded in the heart.

More Recent IVC Filter Lawsuit News:

No-Cost, No-Obligation Bard IVC Filter Lawsuit Case Review for Persons or Families of Persons Who Suffered from Organ Damage, Severe Bleeding, Stroke, or Death

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.